Hologic Stock Today
| HOLX Stock | USD 75.00 0.17 0.23% |
PerformanceGood
| Odds Of DistressLow
|
Hologic is trading at 75.00 as of the 13th of December 2025; that is 0.23 percent increase since the beginning of the trading day. The stock's open price was 74.83. Hologic has less than a 9 % chance of experiencing financial distress in the next few years and had a good performance during the last 90 days. Note, on November 14, 2025, Representative Ro Khanna of US Congress acquired under $15k worth of Hologic's common stock.
Business Domain Health Care Equipment & Services | IPO Date 21st of June 1990 | Category Healthcare | Classification Health Care |
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. The company has 222.91 M outstanding shares of which 4.32 M shares are currently shorted by private and institutional investors with about 1.22 trading days to cover. More on Hologic
Moving together with Hologic Stock
Moving against Hologic Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Hologic Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman, CEO and Pres | Stephen MacMillan | ||||
| Thematic Ideas | (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP 500 Index, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, SRI Sustainable Growth, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Excise Tax Activities | Animal Testing | ||||
| Average Analyst Recommendation | |||||
Debt LevelsHologic can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hologic's financial leverage. It provides some insight into what part of Hologic's total assets is financed by creditors.
| |||||
Hologic (HOLX) is traded on NASDAQ Exchange in USA and employs 7,070 people. Hologic is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 16.72 B. Hologic conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 222.91 M outstanding shares of which 4.32 M shares are currently shorted by private and institutional investors with about 1.22 trading days to cover.
Hologic currently holds about 2.39 B in cash with 1.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.59.
Check Hologic Probability Of Bankruptcy
Ownership AllocationHologic has a total of 222.91 Million outstanding shares. The majority of Hologic outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Hologic to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Hologic. Please pay attention to any change in the institutional holdings of Hologic as this could imply that something significant has changed or is about to change at the company. Also note that almost one million five hundred fifteen thousand seven hundred fifty-six invesors are currently shorting Hologic expressing very little confidence in its future performance.
Check Hologic Ownership Details
Hologic Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2025-06-30 | 2.8 M | |
| Arrowstreet Capital Limited Partnership | 2025-06-30 | 2.8 M | |
| Norges Bank | 2025-06-30 | 2.8 M | |
| Ubs Asset Mgmt Americas Inc | 2025-06-30 | 2.6 M | |
| Nordea Investment Mgmt Bank Demark A/s | 2025-06-30 | 2.6 M | |
| Dimensional Fund Advisors, Inc. | 2025-06-30 | 2.5 M | |
| Morgan Stanley - Brokerage Accounts | 2025-06-30 | 2.4 M | |
| Alliancebernstein L.p. | 2025-06-30 | 2.2 M | |
| Ameriprise Financial Inc | 2025-06-30 | 1.9 M | |
| Vanguard Group Inc | 2025-06-30 | 26.8 M | |
| T. Rowe Price Investment Management,inc. | 2025-06-30 | 24.1 M |
Hologic Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Hologic market risk premium is the additional return an investor will receive from holding Hologic long position in a well-diversified portfolio.
| Mean Deviation | 0.7888 | |||
| Semi Deviation | 0.845 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.07 |
Hologic Stock Against Markets
Hologic Corporate Management
| Mark Irving | VP Secretary | Profile | |
| Paul Malenchini | Chief Officer | Profile | |
| Peter Dunne | Senior Resources | Profile | |
| Benjamin Cohn | Principal Chief Accounting Officer | Profile | |
| Erik Anderson | Division Solutions | Profile | |
| Kevin Thornal | Group Solutions | Profile |
Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.